F. Hoffmann-La Roche===Genentech
Tracked across 2 events · 16 articles · First seen Mar 11, 2026 · Last active Mar 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
F. Hoffmann-La Roche===Genentech, a wholly owned member of the Roche Group, will benefit from the expanded AI infrastructure, particularly in its Research and Early Development efforts, enabling more sophisticated predictive models.
Mar 16, 2026 · 7 articles
Business
Teresa Montagut previously led cancer immunotherapy programs at F. Hoffmann-La Roche===Genentech.
Mar 11, 2026 · 9 articles
Teresa Montagut
former employee
↔
F. Hoffmann-La Roche===Genentech
Teresa Montagut previously led programs at F. Hoffmann-La Roche===Genentech.
Aviv Regev
Executive Vice President
↔
F. Hoffmann-La Roche===Genentech
Aviv Regev is Executive Vice President and Head of F. Hoffmann-La Roche===Genent
NEWSDESK
Track F. Hoffmann-La Roche===Genentech live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard